These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
318 related items for PubMed ID: 15181132
1. Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG. Minn H, Salonen A, Friberg J, Roivainen A, Viljanen T, Långsjö J, Salmi J, Välimäki M, Någren K, Nuutila P. J Nucl Med; 2004 Jun; 45(6):972-9. PubMed ID: 15181132 [Abstract] [Full Text] [Related]
5. Computed tomography, magnetic resonance imaging and 11C-metomidate positron emission tomography for evaluation of adrenal incidentalomas. Hennings J, Hellman P, Ahlström H, Sundin A. Eur J Radiol; 2009 Feb; 69(2):314-23. PubMed ID: 18082990 [Abstract] [Full Text] [Related]
6. The role of PET in localization of neuroendocrine and adrenocortical tumors. Eriksson B, Bergström M, Sundin A, Juhlin C, Orlefors H, Oberg K, Långström B. Ann N Y Acad Sci; 2002 Sep; 970():159-69. PubMed ID: 12381551 [Abstract] [Full Text] [Related]
7. Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn's adenomas. Burton TJ, Mackenzie IS, Balan K, Koo B, Bird N, Soloviev DV, Azizan EA, Aigbirhio F, Gurnell M, Brown MJ. J Clin Endocrinol Metab; 2012 Jan; 97(1):100-9. PubMed ID: 22112805 [Abstract] [Full Text] [Related]
9. Differentiating adrenal adenomas from nonadenomas using (18)F-FDG PET/CT: quantitative and qualitative evaluation. Caoili EM, Korobkin M, Brown RK, Mackie G, Shulkin BL. Acad Radiol; 2007 Apr; 14(4):468-75. PubMed ID: 17368217 [Abstract] [Full Text] [Related]
10. 18F-FDG PET/CT in the evaluation of adrenal masses. Metser U, Miller E, Lerman H, Lievshitz G, Avital S, Even-Sapir E. J Nucl Med; 2006 Jan; 47(1):32-7. PubMed ID: 16391184 [Abstract] [Full Text] [Related]
16. 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. Ho CL, Yu SC, Yeung DW. J Nucl Med; 2003 Feb; 44(2):213-21. PubMed ID: 12571212 [Abstract] [Full Text] [Related]
17. The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses. Maurea S, Klain M, Mainolfi C, Ziviello M, Salvatore M. J Nucl Med; 2001 Jun; 42(6):884-92. PubMed ID: 11390552 [Abstract] [Full Text] [Related]
18. Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET. Torizuka T, Kanno T, Futatsubashi M, Okada H, Yoshikawa E, Nakamura F, Takekuma M, Maeda M, Ouchi Y. J Nucl Med; 2003 Jul; 44(7):1051-6. PubMed ID: 12843219 [Abstract] [Full Text] [Related]
19. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas. Sperti C, Bissoli S, Pasquali C, Frison L, Liessi G, Chierichetti F, Pedrazzoli S. Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094 [Abstract] [Full Text] [Related]
20. Does 18F-FDG PET/MRI reduce the number of indeterminate abdominal incidentalomas compared with 18F-FDG PET/CT? Schaarschmidt BM, Grueneisen J, Heusch P, Gomez B, Umutlu L, Ruhlmann V, Rosenbaum-Krumme S, Antoch G, Buchbender C. Nucl Med Commun; 2015 Jun; 36(6):588-95. PubMed ID: 25759944 [Abstract] [Full Text] [Related] Page: [Next] [New Search]